P288 Is it safe to discontinue long-term trastuzumab containing therapy after radiological complete response (rCR) in metastatic HER-2 positive breast cancer (MBC)?

• M. Calamac,
• N. Stanic,
• O. Djurmez,
• M. Dimitrijevic,
• J. Vukosavljevic,
• K. Serovic,
• J. Oblakovic-Babic,
• I. Minic,
• I. Bozovic-Spasojevic

Affiliations

M. Calamac

N. Stanic

O. Djurmez

M. Dimitrijevic

J. Vukosavljevic

K. Serovic

J. Oblakovic-Babic

I. Minic

I. Bozovic-Spasojevic